상업 바이오테크놀러지용 분리 시스템 시장 규모, 점유율, 동향 분석 보고서 : 방법별, 용도별, 지역별, 부문별 예측(2024-2030년)

Separation Systems For Commercial Biotechnology Market Size, Share & Trends Analysis Report By Method (Conventional Methods, Modern Methods), By Application (Pharmaceutical, Food & Cosmetics), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,194,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,571,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,325,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

상업 바이오테크놀러지용 분리 시스템 시장 성장 및 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 상업 바이오테크놀러지용 분리 시스템 세계 시장 규모는 2024년부터 2030년까지 연평균 6.8% 성장하여 2030년에는 405억 5,000만 달러에 달할 것으로 예상됩니다.

첨단 제품을 개발하기 위한 생명공학 분야의 집중적인 연구가 향후 몇 년 동안 성장을 촉진할 것으로 예상됩니다. 또한, 상업적 생산을 가속화하기 위해 이 분야의 주요 산업체들의 기여가 시장을 견인할 것으로 예상됩니다.

정부기관은 신기술 개발을 위해 중소기업에 자금을 지원하고 있습니다. 이를 통해 생체 분자의 분리 및 정제에 사용되는 대규모 업스트림 바이오프로세싱 시스템의 효율성을 높일 수 있을 것으로 기대됩니다. 이러한 장비는 식품 및 화장품, 농업, 플라스틱, 화학제품 생산에 널리 사용되고 있습니다.

또한, 농산물 가공, 화학, 플라스틱 등 다양한 산업에서 기술적으로 진보된 일회용 바이오프로세싱 시스템의 보급은 업스트림 프로세싱 분야의 성장에 기여하고 있습니다. 만성적이고 심각한 대사 및 유전성 질환 환자의 증가로 인해 잠재적 치료제에 대한 수요가 증가하고 있습니다. 바이오의약품에 대한 수요 증가는 유리한 성장을 가져올 가능성이 높습니다.

또한, 헬스케어 개혁의 변화와 산업계, 정부, 연구기관의 민관 협력으로 인해 분리법의 기술적 측면이 개선될 것으로 예상됩니다. 따라서 예측 기간 동안 상업용 분리 시장의 성장을 크게 촉진할 것으로 예상됩니다.

상업 바이오테크놀러지용 분리 시스템 시장 보고서 하이라이트

• 전통적인 분리 기술은 이 부문의 기술 발전으로 인해 가장 큰 수익 점유율을 차지할 것으로 추정됩니다.
• 그러나 현대적 방법은 이러한 기술의 채택이 증가함에 따라 향후 몇 년 동안 가장 빠른 속도로 성장할 것으로 예상됩니다.
• 제품 성능의 기술적 발전은 상업 바이오테크놀러지용 분리 시스템 시장을 견인할 것으로 예상됩니다.
• 제약 산업은 치료제 상용화를 위한 시스템의 높은 사용률로 인해 가장 큰 매출 점유율을 차지했습니다.
• 다양한 만성질환의 유병률 증가가 간접적으로 성장을 촉진하고 있습니다.
• 북미는 적절한 행정 지원, 광범위한 조사 및 확립된 산업 프레임워크를 통해 시장을 독점하고 있습니다.
• 아시아태평양은 선진화된 산업화와 정부의 적극적인 지원으로 예측 기간 동안 가장 빠른 성장을 보일 것으로 예상됩니다.
• 비공개 기업은 제품 개발을 가속화하고 새로운 시스템을 출시하기 위해 학계, 민간 기업 및 공공 기관과 협력 관계를 맺고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 상업 바이오테크놀러지용 분리 시스템 변수, 동향, 범위

• 시장 소개/계통 전망
• 시장 규모와 성장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 상업 바이오테크놀러지용 분리 시스템 시장 분석 툴
  • Porters 분석
  • PESTEL 분석

제4장 상업 바이오테크놀러지용 분리 시스템 : 방법 추정·동향 분석

• 부문 대시보드
• 상업 바이오테크놀러지용 분리 시스템 : 방법 변동 분석, 2023년 및 2030년
• 기존 방법
• 최신 방법

제5장 상업 바이오테크놀러지용 분리 시스템 : 용도 추정·동향 분석

• 부문 대시보드
• 상업 바이오테크놀러지용 분리 시스템 : 용도 변동 분석, 2023년 및 2030년
• 제약
  • 백신
  • 단백질
  • 호르몬/인슐린
  • 효소
  • 인간 혈장 분획
  • 포유류 세포배양
• 식품·화장품
• 농업
• 기타

제6장 상업 바이오테크놀러지용 분리 시스템 : 지역 추정·동향 분석

• 상업 바이오테크놀러지용 분리 시스템 시장 점유율, 지역별, 2023년 및 2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제7장 경쟁 상황

• 주요 시장 진출 기업의 최근 동향과 영향 분석
• 기업 분류
• 기업 히트맵 분석
• 기업 개요
  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • Horizon Discovery Ltd.
  • OriGene Technologies, Inc.
  • Oxford Biomedica PLC
  • SignaGen Laboratories
  • Flash Therapeutics
  • Takara Bio Inc.
  • Bio-Rad Laboratories, Inc.
  • System Biosciences, LLC.
  • Promega Corporation
  • F. Hoffmann-La Roche Ltd
  • Revvity
  • Catalent, Inc

ksm

영문 목차

영문목차

Separation Systems For Commercial Biotechnology Market Growth & Trends:

The global separation system for commercial biotechnology market size is expected to reach USD 40.55 billion by 2030, expanding at a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Intensive research in the field of biotechnology to develop advanced products is expected to boost growth in the coming years. Moreover, contributions of leading industrial entities in this sector for accelerating commercial production is anticipated to drive the market.

Government bodies are providing funds to small & medium enterprises for the development of novel technologies. This is expected to enhance the efficiency of large-scale upstream bioprocessing systems used for separation & purification of biomolecules. Such instruments are extensively used for the production of food & cosmetics, agriculture, plastics, and chemicals.

Moreover, the popularity of technologically advanced single-use bioprocessing systems in various industries, such as agro-processing, chemical & plastics is contributing toward the growth of the upstream processing sector. Rising cases of chronic & severe metabolic & genetic disorders are ultimately increasing the demand for potential therapeutics. Rising demand for biopharmaceuticals is likely to result in lucrative growth.

Furthermore, changing healthcare reforms and public-private collaborations among industrial players, government, and research institutions are expected to improve the technological aspects of separation methods. Thus, in turn, is anticipated to significantly render the growth of commercial separation market over the forecast period.

Separation Systems For Commercial Biotechnology Market Report Highlights:

• Conventional separation techniques are estimated to account for the largest revenue share owing to technological advancements in the segment.
• However, modern methods are anticipated to grow at the fastest pace in the coming years due to the rise in adoption of these technologies.
• Technological advancements in product capabilities are anticipated to boost the separation systems for commercial biotechnology market.
• Pharmaceutical industry accounted for the largest revenue share owing to higher usage of systems for commercialization of therapeutics.
• Rising prevalence of various chronic disorders is indirectly boosting growth.
• North America dominated the market with adequate administrative support, extensive research, and well-established industrial framework.
• Asia Pacific region is expected to exhibit the fastest growth over the forecast period owing to progressive industrialization and favorable government support.
• Companies are entering into collaborations with academic institutions, private, and public entities to accelerate product development and launch novel systems.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Separation Systems for Commercial Biotechnology Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Separation Systems for Commercial Biotechnology Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Separation Systems for Commercial Biotechnology Market: Method Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Separation Systems for Commercial Biotechnology Market: Method Movement Analysis, 2023 & 2030 (USD Million)
• 4.3. Conventional Methods
  • 4.3.1. Conventional Methods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.2. Chromatography
    • 4.3.2.1. Chromatography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.3. Flow Cytometry
    • 4.3.3.1. Flow Cytometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.4. Membrane Filtration
    • 4.3.4.1. Membrane Filtration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.5. Electrophoresis
    • 4.3.5.1. Electrophoresis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.6. Centrifugation
    • 4.3.6.1. Centrifugation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Modern Methods
  • 4.4.1. Modern Methods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Microarray
    • 4.4.2.1. Microarray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Lab-on-a-chip
    • 4.4.3.1. Lab-on-a-chip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Magnetic Separation
    • 4.4.4.1. Magnetic Separation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Biochip
    • 4.4.5.1. Biochip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Separation Systems for Commercial Biotechnology Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Separation Systems for Commercial Biotechnology Market: Application Movement Analysis, 2023 & 2030 (USD Million)
• 5.3. Pharmaceutical
  • 5.3.1. Pharmaceutical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Vaccines
    • 5.3.2.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Proteins
    • 5.3.3.1. Proteins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.4. Hormones/Insulin
    • 5.3.4.1. Hormones/Insulin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.5. Enzymes
    • 5.3.5.1. Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.6. Human Blood Plasma Fractionation
    • 5.3.6.1. Human Blood Plasma Fractionation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.7. Mammalian Cell Cultures
    • 5.3.7.1. Mammalian Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Food & Cosmetics
  • 5.4.1. Food & Cosmetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Agriculture
  • 5.5.1. Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Separation Systems for Commercial Biotechnology Market: Regional Estimates & Trend Analysis

• 6.1. Separation Systems for Commercial Biotechnology Market Share, By Region, 2023 & 2030 (USD Million)
• 6.2. North America
  • 6.2.1. North America Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. U.S. Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Canada Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Mexico Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. UK Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Germany Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. France Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Italy Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Spain Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Denmark Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Sweden Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Norway Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Japan Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. China Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. India Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. Australia
    • 6.4.5.1. Australia Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. South Korea
    • 6.4.6.1. South Korea Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. Thailand
    • 6.4.7.1. Thailand Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Brazil Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Argentina Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East and Africa
  • 6.6.1. Middle East and Africa Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. South Africa Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Saudi Arabia Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. UAE Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Kuwait Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Thermo Fisher Scientific Inc.
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/Strategic Initiatives
  • 7.4.2. QIAGEN
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/Strategic Initiatives
  • 7.4.3. Horizon Discovery Ltd.
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/Strategic Initiatives
  • 7.4.4. OriGene Technologies, Inc.
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/Strategic Initiatives
  • 7.4.5. Oxford Biomedica PLC
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/Strategic Initiatives
  • 7.4.6. SignaGen Laboratories
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/Strategic Initiatives
  • 7.4.7. Flash Therapeutics
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/Strategic Initiatives
  • 7.4.8. Takara Bio Inc.
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/Strategic Initiatives
  • 7.4.9. Bio-Rad Laboratories, Inc.
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/Strategic Initiatives
  • 7.4.10. System Biosciences, LLC.
    • 7.4.10.1. Participant's Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Recent Developments/Strategic Initiatives
  • 7.4.11. Promega Corporation
    • 7.4.11.1. Participant's Overview
    • 7.4.11.2. Financial Performance
    • 7.4.11.3. Product Benchmarking
    • 7.4.11.4. Recent Developments/Strategic Initiatives
  • 7.4.12. F. Hoffmann-La Roche Ltd
    • 7.4.12.1. Participant's Overview
    • 7.4.12.2. Financial Performance
    • 7.4.12.3. Product Benchmarking
    • 7.4.12.4. Recent Developments/Strategic Initiatives
  • 7.4.13. Revvity
    • 7.4.13.1. Participant's Overview
    • 7.4.13.2. Financial Performance
    • 7.4.13.3. Product Benchmarking
    • 7.4.13.4. Recent Developments/Strategic Initiatives
  • 7.4.14. Catalent, Inc
    • 7.4.14.1. Participant's Overview
    • 7.4.14.2. Financial Performance
    • 7.4.14.3. Product Benchmarking
    • 7.4.14.4. Recent Developments/Strategic Initiatives

관련자료